Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-04

Clinical Trial Update: Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the feasibility of switching patients with schizophrenia from any antipsychotic to Seroquel (quetiapine); the study is reported as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED